NeoGenomics to Provide MDx Testing to Aurora Diagnostics | GenomeWeb

NEW YORK (GenomeWeb) – Cancer genetics testing firm NeoGenomics today announced Aurora Diagnostics has selected it to be the primary partner for molecular testing in Aurora's US network of specialized pathology laboratories.

Aurora will be able to standardize oncology molecular testing services across its 19 labs as a result of the deal, NeoGenomics said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.